These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34169259)

  • 1. Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model.
    Bhattacharya M; Lu DY; Ventoulis I; Greenland GV; Yalcin H; Guan Y; Marine JE; Olgin JE; Zimmerman SL; Abraham TP; Abraham MR; Shatkay H
    CJC Open; 2021 Jun; 3(6):801-813. PubMed ID: 34169259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model).
    Bhattacharya M; Lu DY; Kudchadkar SM; Greenland GV; Lingamaneni P; Corona-Villalobos CP; Guan Y; Marine JE; Olgin JE; Zimmerman S; Abraham TP; Shatkay H; Abraham MR
    Am J Cardiol; 2019 May; 123(10):1681-1689. PubMed ID: 30952382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients.
    Lee HJ; Kim HK; Kim M; Moon I; Lee H; Kim BS; Han KD; Park JB; Hwang IC; Yoon YE; Kim YJ; Cho GY; Ommen SR
    Ann Transl Med; 2020 Nov; 8(21):1386. PubMed ID: 33313131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.
    Fauchier L; Bisson A; Bodin A; Herbert J; Spiesser P; Pierre B; Clementy N; Bernard A; Babuty D; Lip GYH
    Stroke; 2022 Feb; 53(2):497-504. PubMed ID: 34601900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
    Hsu JC; Huang YT; Lin LY
    Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics of left atrial appendage thrombus in patients with hypertrophic cardiomyopathy and non-valvular atrial fibrillation].
    Cui J; Du X; Wu JH; Jia CQ; Ruan YF; Ning M; Hu R; Lyu J; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Dec; 47(12):956-962. PubMed ID: 31877590
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Paroxysmal Atrial Fibrillation and Sex Differences in the Prevention of Embolic Stroke in Hypertrophic Cardiomyopathy.
    Komatsu J; Imai RI; Nakaoka Y; Nishida K; Seki SI; Kubo T; Yamasaki N; Kitaoka H; Kubokawa SI; Kawai K; Hamashige N; Doi YL
    Circ Rep; 2021 Apr; 3(5):273-278. PubMed ID: 34007941
    [No Abstract]   [Full Text] [Related]  

  • 9. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.
    Alphonse P; Virk S; Collins J; Campbell T; Thomas SP; Semsarian C; Kumar S
    Clin Res Cardiol; 2021 Apr; 110(4):544-554. PubMed ID: 32880676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation - a nationwide cohort study.
    Lin TT; Sung YL; Ko TY; Lee CK; Lin LY; Juang JJ; Wu CK
    Aging (Albany NY); 2019 Dec; 11(23):11347-11357. PubMed ID: 31794426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of atrial fibrillation in hypertrophic cardiomyopathy.
    Guttmann OP; Pavlou M; O'Mahony C; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; Garcia-Pavia P; McKenna WJ; Omar RZ; Elliott PM;
    Heart; 2017 May; 103(9):672-678. PubMed ID: 27794017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study.
    Jung H; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Thromb Haemost; 2019 Feb; 119(2):285-293. PubMed ID: 30602200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between Multiple Circulating Biomarkers and the Presence of Atrial Fibrillation in Hypertrophic Cardiomyopathy with or Without Left Ventricular Outflow Tract Obstruction.
    Liu L; Wu L; Zheng L; Ding L; Chen G; Fan X; Yao Y
    Int Heart J; 2019 Mar; 60(2):327-335. PubMed ID: 30626765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).
    Guttmann OP; Pavlou M; O'Mahony C; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; Garcia-Pavia P; McKenna WJ; Omar RZ; Elliott PM;
    Eur J Heart Fail; 2015 Aug; 17(8):837-45. PubMed ID: 26183688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Haruki S; Minami Y; Hagiwara N
    Stroke; 2016 Apr; 47(4):936-42. PubMed ID: 26941260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.
    Tian H; Cui J; Yang C; Hu F; Yuan J; Liu S; Yang W; Jiang X; Qiao S
    BMC Cardiovasc Disord; 2018 Nov; 18(1):207. PubMed ID: 30390664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy.
    Fahmy AS; Rowin EJ; Manning WJ; Maron MS; Nezafat R
    Front Cardiovasc Med; 2021; 8():647857. PubMed ID: 34055932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.